.png){kind=icon}
返回
Medication reviews
.png){kind=icon}
OA
AI
DOI：10.1111/j.1365-2125.2012.04331.x.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Recent years have seen a formalization of medication review by pharmacists in all settings of care. This article describes the different types of medication review provided in primary care in the UK National Health Service (NHS), summarizes the evidence of effectiveness and considers how such reviews might develop in the future. Medication review is, at heart, a diagnostic intervention which aims to identify problems for action by the prescriber, the clinican conducting the review, the patient or all three but can also be regarded as an educational intervention to support patient knowledge and adherence. There is good evidence that medication review improves process outcomes of prescribing including reduced polypharmacy, use of more appropriate medicines formulation and more appropriate choice of medicine. When harder outcome measures have been included, such as hospitalizations or mortality in elderly patients, available evidence indicates that whilst interventions could improve knowledge and adherence they did not reduce mortality or hospital admissions with one study showing an increase in hospital admissions. Robust health economic studies of medication reviews remain rare. However a review of cost-effectiveness analyses of medication reviews found no studies in which the cost of the intervention was greater than the benefit. The value of medication reviews is now generally accepted despite lack of robust research evidence consistently demonstrating cost or clinical effectiveness compared with traditional care. Medication reviews can be more effectively deployed in the future by targeting, multi-professional involvement and paying greater attention to medicines which could be safely stopped.
Keyword:
medication review
medicines use review
pharmacists
primary care
期刊
IF:
3
论文数:
8.6K
被引数:
1.8W
机构
引用论文
A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis药剂师主导的用药错误信息技术干预 (PINCER): 一项多中心、整群随机对照试验和成本效益分析.png)
LANCET
OAAI
LANCETIF88.5
OAAI分享收藏Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial药剂师对居住在养老院中的老年人的临床药物审查-随机对照试验AGE AND AGEINGOAAI
AGE AND AGEINGIF7.1
OAAI分享收藏Zenkevitchiidae fam. nov. (Crustacea: Gammaroidea), with description of new subterranean amphipods from extremely deep cave habitatsZenkevitchiidae科 nov.（甲壳纲：Gammaroidea），并描述来自极深洞穴栖息地的新种鼠妇。
PREAI
分享收藏Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patientsOAAI
OAAI分享收藏分享收藏Nonlinear localized states in the vicinity of topological defects in waveguide arrays波导阵列中拓扑缺陷附近的非线性局域态OAAI
OAAI分享收藏
查看更多内容